NewsRx

Search our medical news database

Amilpar

Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007

Published in Law and Health Weekly, March 29th, 2008

Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA), the largest managed care organization in Brazil, announced its consolidated results for the fourth quarter 2007 and full year of 2007. The Company's operational and financial information is presented on a consolidated basis and in Brazilian Reais, in accordance with Brazilian Corporate Law and the Accounts Chart of the Agencia Nacional de Saude - ANS (Brazil's National Health Agency). To access the complete Press Release, access the Company's IR website. 2007 Highlights -- Total membership stood at over 2.69 million at the end of December, a

34.0% increase compared to 2006. -- Adjusted Operating...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook